Lack of correlation between expression of human mammaglobin mRNA in peripheral blood and known prognostic factors for breast cancer patients

Cancer Science

Volumn 94, Issue 1, 2003, Pages 99-102

  Lin, Yung Chang ^a   Chen, Shin Chie ^a   Hsueh, Swei ^a   Lo, Yung Feng ^a   Chow Wu, Ye Hwei ^a   Liaw, I Chin ^a   Cheng, An Joy ^b  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; ESTROGEN; ESTROGEN RECEPTOR; GENE PRODUCT; HUMAN MAMMAGLOBIN GENE; MESSENGER RNA; MOLECULAR MARKER; UNCLASSIFIED DRUG;

ADULT; AGED; ANEUPLOIDY; ARTICLE; BREAST CANCER; CANCER GRADING; CANCER LOCALIZATION; CANCER PATIENT; CANCER RECURRENCE; CANCER SCREENING; CANCER STAGING; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MEMBRANE TRANSPORT; METASTASIS; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; ANEUPLOIDY; BREAST NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM PROTEINS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RISK FACTORS; RNA, MESSENGER; RNA, NEOPLASM; S PHASE; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL; UTEROGLOBIN;

EID: 0037986562     PISSN: 13479032     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2003.tb01359.x     Document Type: Article

References (30)

1. Gianni L, Valagussa P, Zambetti M, Moliterni A, Carpi G, Banodonna G. Adjuvant and neoadjuvant treatment of breast cancer. Semin Oncol 2001; 28: 13-29.
2. Sloane JP, Ormerod MG, Neville AM. Potential pathological application of immunocytochemical methods to the detection of micrometastases. Cancer Res 1980; 40: 3079-82.
3. Cote RJ, Rosen PP, Lesser ML, Old LJ, Osborne MP. Prediction of early relapse in patients with operable breast cancer by detection of occult bone marrow micrometastases. J Clin Oncol 1991; 9: 1749-56.
4. Harbeck N, Untch M, Pache L, Eiermann W. Tumour cell detection in the bone marrow of breast cancer patients at primary therapy: results of a three-year median follow-up. Br J Cancer 1994; 69: 566-71.
5. Ghossenin RA, Juan R. Polymerase chain reaction in the detection of micrometastases and circulating tumor cells. Cancer 1996; 78: 10-6.
6. Salvadori B, Squicciarini P, Rovini D, Orefice S, Andreola S, Rilke F, Barletta L, Menard S, Colnaghi MI. Use of monoclonal antibody MBr1 to detect micrometastases in bone marrow specimen of breast cancer patients. Eur J Cancer 1990; 26: 865-7.
7. Neumaier M, Gerhard M, Wagner C. Diagnosis of micrometastases by the amplification of tissue-specific gene. Gene 1995; 159: 43-7.
8. Mori M, Mimori K, Ueo H, Tsuji K, Shiraishi T, Barnard GF, Sugimachi K, Akiyoshi T. Clinical significance of molecular detection of carcinoma cells in lymph nodes and peripheral blood by reverse transcription-polymerase chain reaction in patients with gastrointestinal or breast cancer. J Clin Oncol 1998; 16: 128-32.
9. Schoenfeld A, Kriger KH, Gomm J, Sinnett HD, Gazet JC, Sacks N, Bender HG, Luqmani Y, Coombes RC. The detection of micrometastases in the peripheral blood and bone marrow of patients with breast cancer using immunohistochemistry and reverse transcriptase polymerase chain reaction for keratin 19. Eur J Cancer 1997; 33: 854-61.
10. Fields KK, Elfenbein GJ, Trudeau WL, Perkins JB, Janssen WE, Moscinski LC. Clinical significance of bone marrow metastases as detected using the polymerase chain reaction in patients with breast cancer undergoing high-dose chemotherapy and autologous bone marrow transplantation. J Clin Oncol 1996; 14: 1868-76.
11. Datta YH, Adams PT, Drobyski WR, Ethier SP, Terry VH, Roth MS. Sensitive detection of occult breast cancer by the reverse transcriptase polymerase chain reaction. J Clin Oncol 1994; 12: 475-82.
12. Ethier SP, Terry VH, Roth MS, Trudeau WL, Field KK. High sensitivity detection of minimal residual breast carcinoma using the polymerase chain reaction and primers for cytokeratin 19. Diagn Mol Pathol 1996; 5: 173-80.
13. Kruger W, Krzizanowski C, Holweg M, Stockschlader M, Kroger N, Jung R, Mross K, Jonat W, Zander AR. Reverse transcriptase/polymerase chain reaction detection of cytokeratin 19 mRNA in bone marrow and blood of breast cancer patients. J Cancer Res Clin Oncol 1996; 122: 679-86.
14. Burchill SA, Bradbury MF, Pittman K, Southgate J, Smith B, Selby P. Detection of epithelial cancer cells in peripheral blood by reverse transcriptase-polymerase chain reaction. Br J Cancer 1995; 71: 278-81.
15. Mori M, Mimori K, Ueo H, Karimine N, Barnard GF, Sugimachi K, Akiyoshi T. Molecular detection of circulating solid carcinoma cells in the peripheral blood: the concept of early systemic disease. Int J Cancer 1996; 68: 739-43.
16. Gerhard M, Juhl H, Kalthoff H, Schreiber HW, Wagener C, Neumaier M. Specific detection of carcinoembryonic antigen-expression tumor cells in bone marrow aspirate by polymerase chain reaction. J Clin Oncol 1994; 12: 725-9.
17. Mapara MY, Korner IJ, Hilderbrandt M, Bargou R, Krahl D, Reichardt P, Dorken B. Monitoring of tumor cell purging after highly efficient immunomagnetic selection of CD34 cells from leukapheresis products in breast cancer patients: comparison of immunohistochemical tumor cell staining and reverse transcriptase-polymerase chain reaction. Blood 1997; 89: 337-44.
18. Raj GV, Moreno LG, Gomella LG. Utilization of polymerase chain reaction technology in the detection of solid tumor. Cancer 1998; 82: 1419-42.
19. Hu XI, Chow WC. Detection of circulating breast cancer cells with multiple-marker RT-PCR assay. Anticancer Res 2001; 21: 421-4.
20. Chelly J, Concordet JP, Kaplan JC, Kahn A. Illegitimate transcription: transcription of any gene in any cell type. Proc Natl Acad Sci USA 1989; 86: 2617-21.
21. Bastick PJ, Chatterjee S, Chi DD, Huynh KT, Giuliano AE, Cote R, Hoon DS. Limitation of specific reverse-transcriptase polymerase chain reaction markers in the detection of metastases in the lymph nodes and blood of breast cancer patients. J Clin Oncol 1998; 16: 2632-40.
22. Watson MA, Fleming TP. Mammaglobin, a mammary-specific member of the uteroglobin gene family, is overexpressed in human breast cancer. Cancer Res 1996; 56: 860-5.
23. Zach O, Kasparu H, Krieger O, Hehenwarter W, Girschikofsky M, Lutz D. Detection of circulating mammary carcinoma cells in the peripheral blood of breast cancer patients via a nested reverse transcriptase polymerase chain reaction assay for mammaglobin mRNA, J Clin Oncol 1999; 17: 2015-9.
24. Grunewald K, Haun M, Urbanek M, Figel M, Muller-Holzner E, Gunsilius E, Dunser M, Marth C, Castl G. Mammaglobin gene expression: a superior marker of breast cancer cells in peripheral blood in comparison to epidermal-growth-factor receptor and cytokeratin 19. Lab Invest 2000; 80: 1071-7.
25. Corradini P, Voena C, Astolfi M, Pilotti S, Arrigoni G, Bregni M. Pileri A, Gianni AM. Mapsin and mammaglobin genes are specific markers for RT-PCR detection of minimal residual disease in patients with breast cancer. Ann Oncol 2001; 12: 1693-8.
26. Watson MA, Dintzis S, Darrow CM, Voss LE, DiPersio J, Jensen R, Fleming TP. Mammaglobin expression in primary, metastatic and occult breast cancer. Cancer Res 1999; 59: 3028-31.
27. Leygue E, Snell L, Dotzlaw H, Hole K, Troup S, Hiller-Hitchcock T, Murphy LC, Watson PH. Mammaglobin, a potential marker of breast cancer nodal metastasis. J Pathol 1999; 189: 28-33.
28. Suchy B, Austrup F, Driesel G., Edre C, Kusiak I, Uciechowski P, Grill H-J, Giesing M. Detection of mammaglobin expression cells in blood of breast cancer patients. Cancer Lett 2000; 158: 171-8.
29. Winner EP, Morrow M, Osborne CK, Harris JA. Malignant tumors of the breast. In: Devitta VT, Hellman S, Rosenberg SA, editors. Cancer, principles and practice of oncology. 6th ed. Philadelphia: Lippincott Williams & Wilkins; 2001. p.1651-717.
30. Funke I, Schraut W. Meta-analysis of studies on bone marrow micrometastases: an independent prognostic impact remains to be substantiated. J Clin Oncol 1998; 16: 557-66.